Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
7,301
-1,135
-13% -$53.2K ﹤0.01% 1259
2026
Q1
$400K Buy
8,436
+1,216
+17% +$62.2K ﹤0.01% 1070
2025
Q4
$499K Buy
7,220
+70
+1% +$4.84K 0.01% 926
2025
Q3
$515K Buy
7,150
+307
+4% +$23.7K 0.01% 911
2025
Q2
$533K Sell
6,843
-198
-3% -$16K 0.01% 861
2025
Q1
$573K Buy
7,041
+1,068
+18% +$93.5K 0.01% 767
2024
Q4
$547K Buy
5,973
+791
+15% +$63.2K 0.01% 857
2024
Q3
$318K Buy
5,182
+756
+17% +$42.4K ﹤0.01% 1172
2024
Q2
$242K Buy
+4,426
New +$250K ﹤0.01% 1222

Other funds holding DOCU

Choreo LLC's DOCU Position: Q2 2026 in Review

Choreo LLC reduced its DocuSign (DOCU) stake by 13% in Q2 2026, selling an estimated $53.2K and leaving 7,301 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Choreo LLC first reported a position in DOCU in Q2 2024 and has held it in 9 quarters since. The position peaked at $573K in Q1 2025. 670 funds tracked by Wall St. Rank hold DOCU as of Q2 2026.

  • Choreo LLC held 7,301 shares of DocuSign worth $324K as of Q2 2026.
  • Choreo LLC sold 1,135 DocuSign shares in Q2 2026, an estimated $53.2K.
  • DocuSign made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1259 holding.
  • Choreo LLC first reported a position in DocuSign in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's DocuSign position peaked at $573K in Q1 2025.
  • 670 funds tracked by Wall St. Rank held DocuSign as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.